Article 51WBH COVID-19 antiviral: FDA oks human clinical trials for EIDD-2801

COVID-19 antiviral: FDA oks human clinical trials for EIDD-2801

by
Press Release
from Outbreak News Today on (#51WBH)

Human clinical trials may begin on an antiviral compound which was discovered and developed by Emory University and shows promise as a potential treatment for COVID-19. The U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug application by Drug Innovation Ventures at Emory (DRIVE), LLC, wholly owned by Emory University, for EIDD-2801. ["]

The post COVID-19 antiviral: FDA oks human clinical trials for EIDD-2801 appeared first on Outbreak News Today.

OutbreakNewsToday?d=yIl2AUoC8zA OutbreakNewsToday?d=qj6IDK7rITs OutbreakNewsToday?d=63t7Ie-LG7Y
External Content
Source RSS or Atom Feed
Feed Location http://feeds.feedburner.com/OutbreakNewsToday
Feed Title Outbreak News Today
Feed Link https://outbreaknewstoday.com/
Feed Copyright The Global Dispatch, Inc
Reply 0 comments